Pandemic Led to Rapid Adoption of Telemental Health for Those With Schizophrenia
By Elana Gotkine HealthDay Reporter
FRIDAY, Jan. 17, 2025 -- For Medicaid beneficiaries with schizophrenia, delivery of mental health care through telehealth (telemental health care) diffused rapidly after onset of the COVID-19 pandemic, according to a study published online Jan. 16 in JAMA Network Open.
Sharon-Lise Normand, Ph.D., from Harvard Medical School in Boston, and colleagues conducted a retrospective cohort study using New York State Medicaid data from March 1, 2019, to Feb. 29, 2020 (prepandemic period) and from March 11, 2020, to March 31, 2021 (pandemic period) from 261 agencies serving 30,990 beneficiaries with schizophrenia with one or more mental health visits.
Of the agencies included in the study, six (2 percent) and 248 (95 percent) never adopted telemental health care and reached 10 percent cumulative telemental health care visits in a mean of 18 days, respectively. The researchers observed no association for mean agency prepandemic share of beneficiaries belonging to racial or ethnic minority groups with telemental health care diffusion. Faster diffusion was seen in state-operated versus free-standing agencies (hazard ratio, 2.44). Time to first telemental health care visit was slower in every racial and ethnic minority group relative to White beneficiaries (hazard ratios, 0.93, 0.90, and 0.95 for Asian or other, Black, and Latinx, respectively). Regardless of pandemic severity and area, beneficiaries from at least one racial or ethnic minority group were less likely than White beneficiaries to have a telemental health care visit; when pandemic severity was higher, the differences narrowed.
"States should monitor the diffusion of innovations among vulnerable populations, investigating whether adoption speed varies by race and ethnicity," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Further Support and Information on COVID-19
Read this next
Chronic Exposure to Systemic Inflammation May Increase Risk for Affective Disorders
THURSDAY, July 3, 2025 -- For individuals with specific autoimmune conditions, there appears to be an increased risk for affective disorders, according to a study published online...
Weekly LYN-005 Provides Sustained Risperidone Release in Schizophrenia
WEDNESDAY, June 18, 2025 -- For patients with schizophrenia, weekly LYN-005 provides sustained release of risperidone at therapeutic concentrations, according to a study published...
Better Adherence to Antipsychotics Linked to Lower Vehicle Crash Risk
MONDAY, June 9, 2025 -- For drivers with schizophrenia, better adherence to antipsychotic medications is associated with lower motor vehicle crash risk, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.